Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.75 |
| ▸ | APAF1 | O14727 | 2/20 | 0.75 |
| ▸ | LMNA | P02545 | 1/20 | 0.75 |
| ▸ | TSHR | P16473 | 1/20 | 0.75 |
| ▸ | APEX1 | P27695 | 1/20 | 0.75 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.75 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.75 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.75 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.75 |
| ▸ | MAPT | P10636 | 3/20 | 0.74 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.74 |
| ▸ | MMP2 | P08253 | 1/20 | 0.74 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.74 |
| ▸ | CNR1 | P21554 | 1/20 | 0.74 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.74 |
| ▸ | NR1I2 | O75469 | 6/20 | 0.58 |
| ▸ | HTR2C | P28335 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | PPARG | P37231 | 2/20 | 0.56 |
| ▸ | ALB | P02768 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10401059 | 1.00 | TDP1 (0.75) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL4627396 | 1.00 | TDP1 (0.75) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL14600780 | 1.00 | TDP1 (0.75) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL4124254 | 1.00 | TDP1 (0.75) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL4124260 | 1.00 | TDP1 (0.75) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL4627402 | 1.00 | TDP1 (0.75) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL4141299 | 1.00 | TDP1 (0.75) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL4141307 | 1.00 | TDP1 (0.75) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL3299039 | 0.94 | TDP1 (0.67) | TDP1APAF1LMNATSHRAPEX1 | |
| SCHEMBL4132476 | 0.94 | TDP1 (0.67) | TDP1APAF1LMNATSHRAPEX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1572699-B1 | CRYSTALLINE CEFDINIR SALTS | ANTIBIOTICOS SPA (IT) | 2007-02-14 | — | — | EP | disclosed |
| US-7173126-B2 | Crystalline cefdinir salts | ANTIBIOTICOS S.P.A. (IT) | 2007-02-06 | — | — | US | disclosed |
| US-20060074236-A1 | Crystalline cefdinir salts | ANTIBIOTICOS S.P.A. (IT) | 2006-04-06 | — | — | US | disclosed |
| EP-1572699-A1 | CRYSTALLINE CEFDINIR SALTS | Antibioticos S.p.A. (IT) | 2005-09-14 | — | — | EP | disclosed |
| WO-2004056835-A1 | CRYSTALLINE CEFDINIR SALTS | ANTIBIOTICOS S.P.A. (IT) | 2004-07-08 | — | — | WO | disclosed |
| US-4935508-A | Acylation of 7-aminocephalosporin with alkyl 2-(2-amino-thiazol-4-yl)-2-oximinoacetate | BRISTOL-MYERS COMPANY (US) | 1990-06-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060074236-A1 | Crystalline cefdinir salts | CPN1, DCXR, C1R | TDP1 4371/4885APAF1 4185/4885LMNA 4653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.